ANSLY
Price
$90.19
Change
+$1.62 (+1.83%)
Updated
Sep 8 closing price
Capitalization
3.08B
IOBCF
Price
$13.60
Change
-$0.35 (-2.51%)
Updated
Sep 12 closing price
Capitalization
367.87M
Interact to see
Advertisement

ANSLY vs IOBCF

Header iconANSLY vs IOBCF Comparison
Open Charts ANSLY vs IOBCFBanner chart's image
Ansell
Price$90.19
Change+$1.62 (+1.83%)
Volume$285
Capitalization3.08B
Ion Beam Applications S.A
Price$13.60
Change-$0.35 (-2.51%)
Volume$150
Capitalization367.87M
ANSLY vs IOBCF Comparison Chart in %
Loading...
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANSLY vs. IOBCF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANSLY is a Buy and IOBCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ANSLY: $90.19 vs. IOBCF: $13.60)
Brand notoriety: ANSLY and IOBCF are both not notable
ANSLY represents the Pharmaceuticals: Other, while IOBCF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ANSLY: 133% vs. IOBCF: 51%
Market capitalization -- ANSLY: $3.08B vs. IOBCF: $367.87M
ANSLY [@Pharmaceuticals: Other] is valued at $3.08B. IOBCF’s [@Medical/Nursing Services] market capitalization is $367.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.89B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANSLY’s FA Score shows that 1 FA rating(s) are green whileIOBCF’s FA Score has 1 green FA rating(s).

  • ANSLY’s FA Score: 1 green, 4 red.
  • IOBCF’s FA Score: 1 green, 4 red.
According to our system of comparison, ANSLY is a better buy in the long-term than IOBCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANSLY’s TA Score shows that 5 TA indicator(s) are bullish while IOBCF’s TA Score has 3 bullish TA indicator(s).

  • ANSLY’s TA Score: 5 bullish, 3 bearish.
  • IOBCF’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ANSLY is a better buy in the short-term than IOBCF.

Price Growth

ANSLY (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while IOBCF (@Medical/Nursing Services) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.61%. For the same industry, the average monthly price growth was +3.37%, and the average quarterly price growth was +9.80%.

Industries' Descriptions

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-1.61% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANSLY($3.08B) has a higher market cap than IOBCF($368M). ANSLY has higher P/E ratio than IOBCF: ANSLY (32.44) vs IOBCF (19.85). ANSLY YTD gains are higher at: 10.890 vs. IOBCF (-1.805).
ANSLYIOBCFANSLY / IOBCF
Capitalization3.08B368M838%
EBITDAN/AN/A-
Gain YTD10.890-1.805-603%
P/E Ratio32.4419.85163%
RevenueN/AN/A-
Total Cash88.5MN/A-
Total Debt806MN/A-
FUNDAMENTALS RATINGS
ANSLY vs IOBCF: Fundamental Ratings
ANSLY
IOBCF
OUTLOOK RATING
1..100
4934
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9287
PRICE GROWTH RATING
1..100
4555
P/E GROWTH RATING
1..100
5896
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOBCF's Valuation (12) in the null industry is in the same range as ANSLY (19). This means that IOBCF’s stock grew similarly to ANSLY’s over the last 12 months.

IOBCF's Profit vs Risk Rating (77) in the null industry is in the same range as ANSLY (100). This means that IOBCF’s stock grew similarly to ANSLY’s over the last 12 months.

IOBCF's SMR Rating (87) in the null industry is in the same range as ANSLY (92). This means that IOBCF’s stock grew similarly to ANSLY’s over the last 12 months.

ANSLY's Price Growth Rating (45) in the null industry is in the same range as IOBCF (55). This means that ANSLY’s stock grew similarly to IOBCF’s over the last 12 months.

ANSLY's P/E Growth Rating (58) in the null industry is somewhat better than the same rating for IOBCF (96). This means that ANSLY’s stock grew somewhat faster than IOBCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANSLYIOBCF
RSI
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 19 days ago
38%
Bullish Trend 29 days ago
50%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
57%
Aroon
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ANSLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IOBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WIMVX12.20N/A
N/A
Segall Bryant & Hamill Glb All Cp Inst
LMSAX41.42N/A
N/A
ClearBridge Small Cap A
PQIAX42.64-0.24
-0.56%
Principal Equity Income A
DFDPX39.50-0.29
-0.73%
DF Dent Premier Growth Investor
LADRX22.80-0.18
-0.78%
Lord Abbett Developing Growth R3

ANSLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANSLY has been loosely correlated with BRSYF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ANSLY jumps, then BRSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANSLY
1D Price
Change %
ANSLY100%
N/A
BRSYF - ANSLY
61%
Loosely correlated
N/A
VERO - ANSLY
38%
Loosely correlated
+0.43%
IOBCF - ANSLY
35%
Loosely correlated
N/A
FSPKF - ANSLY
22%
Poorly correlated
N/A
APYX - ANSLY
21%
Poorly correlated
-0.24%
More

IOBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBCF has been loosely correlated with BRSYF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBCF jumps, then BRSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBCF
1D Price
Change %
IOBCF100%
N/A
BRSYF - IOBCF
39%
Loosely correlated
N/A
ANSLY - IOBCF
37%
Loosely correlated
N/A
LZAGY - IOBCF
23%
Poorly correlated
-1.16%
STSS - IOBCF
22%
Poorly correlated
-3.49%
BMKDF - IOBCF
20%
Poorly correlated
N/A
More